↑ トップへ　← 戻る

Target Gene/Pathway（薬物標的遺伝子／パスウェイリスト）💬 Info on mouse-over

e.g. Sirolimus, アダリムマブ, MAP2K

ABCDEFGH I JKLMNOPQRSTUVWXYZother

194 / 286 pathways

No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related		 KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Acute myeloid leukemia 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
2 Acute myeloid leukemia 💬
 4件: BRAF, FLT3, KIT, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
3 Acute myeloid leukemia 💬
 4件: BRAF, FLT3, KIT, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
4 Acute myeloid leukemia 💬
 2件: FLT3, KIT 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
5 Acute myeloid leukemia 💬
 2件: FLT3, KIT 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
6 Acute myeloid leukemia 💬
 1件: KIT 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
7 Acute myeloid leukemia 💬
 1件: KIT 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
8 Acute myeloid leukemia 💬
 1件: KIT 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
9 Acute myeloid leukemia 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
10 Acute myeloid leukemia 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
11 Acute myeloid leukemia 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
12 Acute myeloid leukemia 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
13 Acute myeloid leukemia 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
14 Acute myeloid leukemia 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
15 Adherens junction 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
16 Adherens junction 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
17 Adherens junction 💬
 2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
18 Adherens junction 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
19 Adherens junction 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
20 Adipocytokine signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
21 Adipocytokine signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
22 Adipocytokine signaling pathway 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
23 Adipocytokine signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
24 Adipocytokine signaling pathway 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
25 Adipocytokine signaling pathway 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
26 Adrenergic signaling in cardiomyocytes 💬
 1件: SCN5A 💬 D00354 💬 Lamotrigine 5件: 13, 34, 38, 114, 144 💬
27 Adrenergic signaling in cardiomyocytes 💬
 1件: SCN5A 💬 D00358 💬 Lidocaine 12件:  6 , 13, 34, 46, 51, 70, 84, 86, 168, 226, 231, 256 💬
28 Adrenergic signaling in cardiomyocytes 💬
 1件: SCN5A 💬 D02086 💬 Lidocaine 12件:  6 , 13, 34, 46, 51, 70, 84, 86, 168, 226, 231, 256 💬
29 Adrenergic signaling in cardiomyocytes 💬
 1件: SCN5A 💬 D08127 💬 Lidocaine 12件:  6 , 13, 34, 46, 51, 70, 84, 86, 168, 226, 231, 256 💬
30 African trypanosomiasis 💬
 4件: IL10, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
31 African trypanosomiasis 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
32 African trypanosomiasis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
33 AGE-RAGE signaling pathway in diabetic complications 💬
 5件: CCL2, IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
34 AGE-RAGE signaling pathway in diabetic complications 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
35 AGE-RAGE signaling pathway in diabetic complications 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
36 AGE-RAGE signaling pathway in diabetic complications 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
37 AGE-RAGE signaling pathway in diabetic complications 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
38 Alanine, aspartate and glutamate metabolism 💬
 4件: ABAT, ALDH5A1, GAD1, GAD2 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
39 Alcoholism 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
40 Alcoholism 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
41 Alcoholism 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
42 Alcoholism 💬
 1件: MAP2K1 💬 D10604 💬 Binimetinib 1件: 34 💬
43 Alcoholism 💬
 1件: MAP2K1 💬 D09666 💬 Selumetinib 1件: 34 💬
44 Alcoholism 💬
 1件: MAP2K1 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
45 Alcoholism 💬
 1件: SLC6A3 💬 D01296 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
46 Alcoholism 💬
 1件: SLC6A3 💬 D04999 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
47 Aldosterone synthesis and secretion 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
48 Allograft rejection 💬
 2件: IL10, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
49 Allograft rejection 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
50 Allograft rejection 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
51 Alzheimer disease 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
52 Alzheimer disease 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
53 Alzheimer disease 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
54 Alzheimer disease 💬
 1件: CSF1 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
55 Alzheimer disease 💬
 1件: CSF1 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
56 Alzheimer disease 💬
 4件: IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
57 Alzheimer disease 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
58 Alzheimer disease 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
59 Alzheimer disease 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
60 Alzheimer disease 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
61 Alzheimer disease 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
62 Alzheimer disease 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
63 Alzheimer disease 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
64 Alzheimer disease 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 16件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
65 Alzheimer disease 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 14件: 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
66 Alzheimer disease 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 9件:  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
67 Alzheimer disease 💬
 1件: PTGS2 💬 D00903 💬 Diclofenac 4件: 13, 34, 46, 271 💬
68 Alzheimer disease 💬
 1件: PTGS2 💬 D00904 💬 Diclofenac 4件: 13, 34, 46, 271 💬
69 Alzheimer disease 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 4件: 13, 34, 46, 271 💬
70 Alzheimer disease 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
71 Alzheimer disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D01068 💬 Vinblastine 1件: 34 💬
72 Alzheimer disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08675 💬 Vinblastine 1件: 34 💬
73 Alzheimer disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D02197 💬 Vincristine 3件: 26, 34, 331 💬
74 Alzheimer disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08679 💬 Vincristine 3件: 26, 34, 331 💬
75 Amoebiasis 💬
 4件: IL10, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
76 Amoebiasis 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
77 Amoebiasis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
78 Amphetamine addiction 💬
 1件: SLC6A3 💬 D01296 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
79 Amphetamine addiction 💬
 1件: SLC6A3 💬 D04999 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
80 AMPK signaling pathway 💬
 1件: HMGCR 💬 D00359 💬 Lovastatin 11件:  6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
81 AMPK signaling pathway 💬
 1件: HMGCR 💬 D00434 💬 Simvastatin 21件:  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
82 AMPK signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
83 AMPK signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
84 AMPK signaling pathway 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
85 Amyotrophic lateral sclerosis 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
86 Amyotrophic lateral sclerosis 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
87 Amyotrophic lateral sclerosis 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
88 Amyotrophic lateral sclerosis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
89 Amyotrophic lateral sclerosis 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
90 Amyotrophic lateral sclerosis 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
91 Amyotrophic lateral sclerosis 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D01068 💬 Vinblastine 1件: 34 💬
92 Amyotrophic lateral sclerosis 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08675 💬 Vinblastine 1件: 34 💬
93 Amyotrophic lateral sclerosis 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D02197 💬 Vincristine 3件: 26, 34, 331 💬
94 Amyotrophic lateral sclerosis 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08679 💬 Vincristine 3件: 26, 34, 331 💬
95 Antifolate resistance 💬
 2件: DHFR, DHFR2 💬 D00142 💬 Methotrexate 35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
96 Antifolate resistance 💬
 2件: DHFR, DHFR2 💬 D02115 💬 Methotrexate 35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
97 Antifolate resistance 💬
 3件: IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
98 Antifolate resistance 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
99 Antifolate resistance 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
100 Antigen processing and presentation 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
101 Antigen processing and presentation 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
102 Antigen processing and presentation 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
103 Apelin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
104 Apelin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
105 Apelin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
106 Apelin signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
107 Apelin signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
108 Apelin signaling pathway 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
109 Apelin signaling pathway 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
110 Apelin signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
111 Apoptosis 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
112 Apoptosis 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
113 Apoptosis 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
114 Apoptosis 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
115 Apoptosis 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
116 Apoptosis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
117 Apoptosis 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
118 Apoptosis 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
119 Arachidonic acid metabolism 💬
 2件: PTGS1, PTGS2 💬 D00217 💬 Acetaminophen 16件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
120 Arachidonic acid metabolism 💬
 2件: PTGS1, PTGS2 💬 D00109 💬 Acetylsalicylic acid 14件: 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
121 Arachidonic acid metabolism 💬
 2件: PTGS1, PTGS2 💬 D00903 💬 Diclofenac 4件: 13, 34, 46, 271 💬
122 Arachidonic acid metabolism 💬
 2件: PTGS1, PTGS2 💬 D00904 💬 Diclofenac 4件: 13, 34, 46, 271 💬
123 Arachidonic acid metabolism 💬
 2件: PTGS1, PTGS2 💬 D07816 💬 Diclofenac 4件: 13, 34, 46, 271 💬
124 Arachidonic acid metabolism 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 9件:  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
125 Asthma 💬
 2件: IL10, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
126 Asthma 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
127 Asthma 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
128 Autoimmune thyroid disease 💬
 1件: IL10 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
129 Autophagy - animal 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
130 Autophagy - animal 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
131 Autophagy - animal 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
132 Autophagy - animal 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
133 Autophagy - animal 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
134 Autophagy - animal 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
135 Autophagy - animal 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
136 Autophagy - animal 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
137 Autophagy - other 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
138 Autophagy - other 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
139 Autophagy - other 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
140 Axon guidance 💬
 1件: ABL1 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
141 Axon guidance 💬
 1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
142 Axon guidance 💬
 1件: ABL1 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
143 Axon guidance 💬
 1件: BMPR2 💬 D03779 💬 Dibotermin alfa 1件: 34 💬
144 Axon guidance 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
145 Axon guidance 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
146 Axon guidance 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
147 B cell receptor signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
148 B cell receptor signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
149 B cell receptor signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
150 B cell receptor signaling pathway 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
151 B cell receptor signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
152 Bacterial invasion of epithelial cells 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
153 beta-Alanine metabolism 💬
 3件: ABAT, GAD1, GAD2 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
154 Bile secretion 💬
 1件: HMGCR 💬 D00359 💬 Lovastatin 11件:  6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
155 Bile secretion 💬
 1件: HMGCR 💬 D00434 💬 Simvastatin 21件:  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
156 Biosynthesis of cofactors 💬
 2件: DHFR, DHFR2 💬 D00142 💬 Methotrexate 35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
157 Biosynthesis of cofactors 💬
 2件: DHFR, DHFR2 💬 D02115 💬 Methotrexate 35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
158 Bladder cancer 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
159 Bladder cancer 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
160 Bladder cancer 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
161 Bladder cancer 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
162 Bladder cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
163 Bladder cancer 💬
 2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
164 Bladder cancer 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
165 Bladder cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
166 Bladder cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
167 Bladder cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
168 Bladder cancer 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
169 Bladder cancer 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
170 Breast cancer 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
171 Breast cancer 💬
 4件: BRAF, FLT4, KIT, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
172 Breast cancer 💬
 4件: BRAF, FLT4, KIT, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
173 Breast cancer 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
174 Breast cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
175 Breast cancer 💬
 2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
176 Breast cancer 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
177 Breast cancer 💬
 1件: FLT4 💬 D03218 💬 Axitinib 1件: 34 💬
178 Breast cancer 💬
 1件: FLT4 💬 D08881 💬 Cediranib 1件: 34 💬
179 Breast cancer 💬
 2件: FLT4, KIT 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
180 Breast cancer 💬
 2件: FLT4, KIT 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
181 Breast cancer 💬
 1件: KIT 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
182 Breast cancer 💬
 1件: KIT 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
183 Breast cancer 💬
 1件: KIT 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
184 Breast cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
185 Breast cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
186 Breast cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
187 Breast cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
188 Breast cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
189 Breast cancer 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
190 Butanoate metabolism 💬
 4件: ABAT, ALDH5A1, GAD1, GAD2 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
191 C-type lectin receptor signaling pathway 💬
 4件: IL10, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
192 C-type lectin receptor signaling pathway 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
193 C-type lectin receptor signaling pathway 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 16件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
194 C-type lectin receptor signaling pathway 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 14件: 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
195 C-type lectin receptor signaling pathway 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 9件:  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
196 C-type lectin receptor signaling pathway 💬
 1件: PTGS2 💬 D00903 💬 Diclofenac 4件: 13, 34, 46, 271 💬
197 C-type lectin receptor signaling pathway 💬
 1件: PTGS2 💬 D00904 💬 Diclofenac 4件: 13, 34, 46, 271 💬
198 C-type lectin receptor signaling pathway 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 4件: 13, 34, 46, 271 💬
199 C-type lectin receptor signaling pathway 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
200 C-type lectin receptor signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
201 C-type lectin receptor signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
202 Calcium signaling pathway 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
203 Calcium signaling pathway 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
204 Calcium signaling pathway 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
205 Calcium signaling pathway 💬
 2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
206 Calcium signaling pathway 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
207 Calcium signaling pathway 💬
 3件: FLT1, FLT4, KDR 💬 D03218 💬 Axitinib 1件: 34 💬
208 Calcium signaling pathway 💬
 3件: FLT1, FLT4, KDR 💬 D08881 💬 Cediranib 1件: 34 💬
209 Calcium signaling pathway 💬
 6件: FLT1, FLT4, KDR, PDGFRA, PDGFRB, RET 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
210 Calcium signaling pathway 💬
 6件: FLT1, FLT4, KDR, PDGFRA, PDGFRB, RET 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
211 Calcium signaling pathway 💬
 4件: FLT4, KDR, PDGFRB, RET 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
212 Calcium signaling pathway 💬
 4件: FLT4, KDR, PDGFRB, RET 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
213 Calcium signaling pathway 💬
 2件: KDR, MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
214 Calcium signaling pathway 💬
 1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
215 Calcium signaling pathway 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
216 Calcium signaling pathway 💬
 2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
217 Calcium signaling pathway 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
218 Calcium signaling pathway 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
219 cAMP signaling pathway 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
220 cAMP signaling pathway 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
221 cAMP signaling pathway 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
222 cAMP signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
223 cAMP signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
224 cAMP signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
225 Cell cycle 💬
 1件: ABL1 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
226 Cell cycle 💬
 1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
227 Cell cycle 💬
 1件: ABL1 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
228 Cellular senescence 💬
 2件: IL1A, IL6 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
229 Cellular senescence 💬
 1件: IL6 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
230 Cellular senescence 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
231 Cellular senescence 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
232 Cellular senescence 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
233 Cellular senescence 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
234 Cellular senescence 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
235 Cellular senescence 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
236 Cellular senescence 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
237 Cellular senescence 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
238 Central carbon metabolism in cancer 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
239 Central carbon metabolism in cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
240 Central carbon metabolism in cancer 💬
 2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
241 Central carbon metabolism in cancer 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
242 Central carbon metabolism in cancer 💬
 5件: FLT3, KIT, PDGFRA, PDGFRB, RET 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
243 Central carbon metabolism in cancer 💬
 5件: FLT3, KIT, PDGFRA, PDGFRB, RET 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
244 Central carbon metabolism in cancer 💬
 5件: FLT3, KIT, PDGFRB, RAF1, RET 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
245 Central carbon metabolism in cancer 💬
 5件: FLT3, KIT, PDGFRB, RAF1, RET 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
246 Central carbon metabolism in cancer 💬
 2件: KIT, PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
247 Central carbon metabolism in cancer 💬
 2件: KIT, PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
248 Central carbon metabolism in cancer 💬
 3件: KIT, PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
249 Central carbon metabolism in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
250 Central carbon metabolism in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
251 Central carbon metabolism in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
252 Central carbon metabolism in cancer 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
253 Central carbon metabolism in cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
254 Central carbon metabolism in cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
255 Central carbon metabolism in cancer 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
256 cGMP-PKG signaling pathway 💬
 3件: ADRA2A, ADRA2B, ADRA2C 💬 D00514 💬 Dexmedetomidine 12件:  2 ,  4 ,  6 , 21, 34, 46, 70, 113, 212, 215, 226, 280 💬
257 cGMP-PKG signaling pathway 💬
 3件: ADRA2A, ADRA2B, ADRA2C 💬 D01205 💬 Dexmedetomidine 12件:  2 ,  4 ,  6 , 21, 34, 46, 70, 113, 212, 215, 226, 280 💬
258 cGMP-PKG signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
259 cGMP-PKG signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
260 cGMP-PKG signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
261 cGMP-PKG signaling pathway 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
262 cGMP-PKG signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
263 Chagas disease 💬
 5件: CCL2, IL10, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
264 Chagas disease 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
265 Chagas disease 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
266 Chemical carcinogenesis 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 16件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
267 Chemical carcinogenesis 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 14件: 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
268 Chemical carcinogenesis 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 9件:  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
269 Chemical carcinogenesis 💬
 1件: PTGS2 💬 D00903 💬 Diclofenac 4件: 13, 34, 46, 271 💬
270 Chemical carcinogenesis 💬
 1件: PTGS2 💬 D00904 💬 Diclofenac 4件: 13, 34, 46, 271 💬
271 Chemical carcinogenesis 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 4件: 13, 34, 46, 271 💬
272 Chemokine signaling pathway 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
273 Chemokine signaling pathway 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
274 Chemokine signaling pathway 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
275 Chemokine signaling pathway 💬
 1件: CCL2 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
276 Chemokine signaling pathway 💬
 1件: MAP2K1 💬 D10604 💬 Binimetinib 1件: 34 💬
277 Chemokine signaling pathway 💬
 1件: MAP2K1 💬 D09666 💬 Selumetinib 1件: 34 💬
278 Chemokine signaling pathway 💬
 1件: MAP2K1 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
279 Choline metabolism in cancer 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
280 Choline metabolism in cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
281 Choline metabolism in cancer 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
282 Choline metabolism in cancer 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
283 Choline metabolism in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
284 Choline metabolism in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
285 Choline metabolism in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
286 Choline metabolism in cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
287 Choline metabolism in cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
288 Choline metabolism in cancer 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
289 Choline metabolism in cancer 💬
 1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
290 Choline metabolism in cancer 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
291 Choline metabolism in cancer 💬
 2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
292 Choline metabolism in cancer 💬
 2件: PDGFRA, PDGFRB 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
293 Choline metabolism in cancer 💬
 2件: PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
294 Choline metabolism in cancer 💬
 2件: PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
295 Choline metabolism in cancer 💬
 2件: PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
296 Cholinergic synapse 💬
 1件: MAP2K1 💬 D10604 💬 Binimetinib 1件: 34 💬
297 Cholinergic synapse 💬
 1件: MAP2K1 💬 D09666 💬 Selumetinib 1件: 34 💬
298 Cholinergic synapse 💬
 1件: MAP2K1 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
299 Chronic myeloid leukemia 💬
 1件: ABL1 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
300 Chronic myeloid leukemia 💬
 1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
301 Chronic myeloid leukemia 💬
 1件: ABL1 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
302 Chronic myeloid leukemia 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
303 Chronic myeloid leukemia 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
304 Chronic myeloid leukemia 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
305 Chronic myeloid leukemia 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
306 Chronic myeloid leukemia 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
307 Chronic myeloid leukemia 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
308 Circadian entrainment 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
309 Cocaine addiction 💬
 1件: SLC6A3 💬 D01296 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
310 Cocaine addiction 💬
 1件: SLC6A3 💬 D04999 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
311 Colorectal cancer 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
312 Colorectal cancer 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
313 Colorectal cancer 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
314 Colorectal cancer 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
315 Colorectal cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
316 Colorectal cancer 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
317 Colorectal cancer 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
318 Colorectal cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
319 Colorectal cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
320 Colorectal cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
321 Colorectal cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
322 Colorectal cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
323 Colorectal cancer 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
324 Coronavirus disease - COVID-19 💬
 4件: CCL2, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
325 Coronavirus disease - COVID-19 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
326 Coronavirus disease - COVID-19 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
327 Coronavirus disease - COVID-19 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
328 Coronavirus disease - COVID-19 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
329 Coronavirus disease - COVID-19 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
330 Coronavirus disease - COVID-19 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
331 Coronavirus disease - COVID-19 💬
 1件: TLR7 💬 D02500 💬 Imiquimod 2件: 34, 51 💬
332 Coronavirus disease - COVID-19 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
333 Cortisol synthesis and secretion 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
334 Cushing syndrome 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
335 Cushing syndrome 💬
 1件: BRAF 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
336 Cushing syndrome 💬
 1件: BRAF 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
337 Cushing syndrome 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
338 Cushing syndrome 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
339 Cushing syndrome 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
340 Cushing syndrome 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
341 Cushing syndrome 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
342 Cushing syndrome 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
343 Cushing syndrome 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
344 Cushing syndrome 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
345 Cytokine-cytokine receptor interaction 💬
 1件: BMPR2 💬 D03779 💬 Dibotermin alfa 1件: 34 💬
346 Cytokine-cytokine receptor interaction 💬
 6件: CCL2, IL10, IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
347 Cytokine-cytokine receptor interaction 💬
 1件: CSF1 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
348 Cytokine-cytokine receptor interaction 💬
 1件: CSF1 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
349 Cytokine-cytokine receptor interaction 💬
 1件: CSF3R 💬 D03235 💬 Filgrastim 33件:  2 ,  6 , 11, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
350 Cytokine-cytokine receptor interaction 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
351 Cytokine-cytokine receptor interaction 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
352 Cytokine-cytokine receptor interaction 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
353 Cytosolic DNA-sensing pathway 💬
 2件: IL1B, IL6 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
354 Cytosolic DNA-sensing pathway 💬
 1件: IL6 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
355 Diabetic cardiomyopathy 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
356 Diabetic cardiomyopathy 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
357 Diabetic cardiomyopathy 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
358 Dilated cardiomyopathy 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
359 Dilated cardiomyopathy 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
360 Dilated cardiomyopathy 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
361 Dopaminergic synapse 💬
 1件: SCN1A 💬 D00354 💬 Lamotrigine 5件: 13, 34, 38, 114, 144 💬
362 Dopaminergic synapse 💬
 1件: SCN1A 💬 D00358 💬 Lidocaine 12件:  6 , 13, 34, 46, 51, 70, 84, 86, 168, 226, 231, 256 💬
363 Dopaminergic synapse 💬
 1件: SCN1A 💬 D02086 💬 Lidocaine 12件:  6 , 13, 34, 46, 51, 70, 84, 86, 168, 226, 231, 256 💬
364 Dopaminergic synapse 💬
 1件: SCN1A 💬 D08127 💬 Lidocaine 12件:  6 , 13, 34, 46, 51, 70, 84, 86, 168, 226, 231, 256 💬
365 Dopaminergic synapse 💬
 1件: SLC6A3 💬 D01296 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
366 Dopaminergic synapse 💬
 1件: SLC6A3 💬 D04999 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
367 EGFR tyrosine kinase inhibitor resistance 💬
 3件: AXL, KDR, MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
368 EGFR tyrosine kinase inhibitor resistance 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
369 EGFR tyrosine kinase inhibitor resistance 💬
 4件: BRAF, KDR, PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
370 EGFR tyrosine kinase inhibitor resistance 💬
 4件: BRAF, KDR, PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
371 EGFR tyrosine kinase inhibitor resistance 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
372 EGFR tyrosine kinase inhibitor resistance 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
373 EGFR tyrosine kinase inhibitor resistance 💬
 2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
374 EGFR tyrosine kinase inhibitor resistance 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
375 EGFR tyrosine kinase inhibitor resistance 💬
 1件: IL6 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
376 EGFR tyrosine kinase inhibitor resistance 💬
 1件: IL6 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
377 EGFR tyrosine kinase inhibitor resistance 💬
 1件: KDR 💬 D03218 💬 Axitinib 1件: 34 💬
378 EGFR tyrosine kinase inhibitor resistance 💬
 1件: KDR 💬 D08881 💬 Cediranib 1件: 34 💬
379 EGFR tyrosine kinase inhibitor resistance 💬
 3件: KDR, PDGFRA, PDGFRB 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
380 EGFR tyrosine kinase inhibitor resistance 💬
 3件: KDR, PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
381 EGFR tyrosine kinase inhibitor resistance 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
382 EGFR tyrosine kinase inhibitor resistance 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
383 EGFR tyrosine kinase inhibitor resistance 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
384 EGFR tyrosine kinase inhibitor resistance 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
385 EGFR tyrosine kinase inhibitor resistance 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
386 EGFR tyrosine kinase inhibitor resistance 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
387 EGFR tyrosine kinase inhibitor resistance 💬
 1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
388 EGFR tyrosine kinase inhibitor resistance 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
389 EGFR tyrosine kinase inhibitor resistance 💬
 2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
390 EGFR tyrosine kinase inhibitor resistance 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
391 EGFR tyrosine kinase inhibitor resistance 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
392 Endocrine and other factor-regulated calcium reabsorption 💬
 1件: VDR 💬 D00188 💬 Cholecalciferol 23件:  6 , 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 84, 85, 96, 97, 162, 202, 228, 271, 298, 299 💬
393 Endocrine resistance 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
394 Endocrine resistance 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
395 Endocrine resistance 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
396 Endocrine resistance 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
397 Endocrine resistance 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
398 Endocrine resistance 💬
 2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
399 Endocrine resistance 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
400 Endocrine resistance 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
401 Endocrine resistance 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
402 Endocrine resistance 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
403 Endocrine resistance 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
404 Endocrine resistance 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
405 Endocrine resistance 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
406 Endocytosis 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
407 Endocytosis 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
408 Endocytosis 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
409 Endocytosis 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
410 Endocytosis 💬
 1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
411 Endocytosis 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
412 Endocytosis 💬
 1件: PDGFRA 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
413 Endocytosis 💬
 1件: PDGFRA 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
414 Endocytosis 💬
 1件: PDGFRA 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
415 Endometrial cancer 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
416 Endometrial cancer 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
417 Endometrial cancer 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
418 Endometrial cancer 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
419 Endometrial cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
420 Endometrial cancer 💬
 2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
421 Endometrial cancer 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
422 Endometrial cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
423 Endometrial cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
424 Endometrial cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
425 Epithelial cell signaling in Helicobacter pylori infection 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
426 Epithelial cell signaling in Helicobacter pylori infection 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
427 Epithelial cell signaling in Helicobacter pylori infection 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
428 Epithelial cell signaling in Helicobacter pylori infection 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
429 Epithelial cell signaling in Helicobacter pylori infection 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
430 Epstein-Barr virus infection 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
431 Epstein-Barr virus infection 💬
 2件: IL6, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
432 Epstein-Barr virus infection 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
433 Epstein-Barr virus infection 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
434 ErbB signaling pathway 💬
 1件: ABL1 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
435 ErbB signaling pathway 💬
 1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
436 ErbB signaling pathway 💬
 1件: ABL1 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
437 ErbB signaling pathway 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
438 ErbB signaling pathway 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
439 ErbB signaling pathway 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
440 ErbB signaling pathway 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
441 ErbB signaling pathway 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
442 ErbB signaling pathway 💬
 2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
443 ErbB signaling pathway 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
444 ErbB signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
445 ErbB signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
446 ErbB signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
447 ErbB signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
448 ErbB signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
449 ErbB signaling pathway 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
450 Estrogen signaling pathway 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
451 Estrogen signaling pathway 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
452 Estrogen signaling pathway 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
453 Estrogen signaling pathway 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
454 Estrogen signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
455 Estrogen signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
456 Estrogen signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
457 Estrogen signaling pathway 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
458 Estrogen signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
459 Fc epsilon RI signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
460 Fc epsilon RI signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
461 Fc epsilon RI signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
462 Fc epsilon RI signaling pathway 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
463 Fc epsilon RI signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
464 Fc epsilon RI signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
465 Fc epsilon RI signaling pathway 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
466 Fc epsilon RI signaling pathway 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
467 Fc gamma R-mediated phagocytosis 💬
 1件: MAP2K1 💬 D10604 💬 Binimetinib 1件: 34 💬
468 Fc gamma R-mediated phagocytosis 💬
 1件: MAP2K1 💬 D09666 💬 Selumetinib 1件: 34 💬
469 Fc gamma R-mediated phagocytosis 💬
 1件: MAP2K1 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
470 Fc gamma R-mediated phagocytosis 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
471 Fc gamma R-mediated phagocytosis 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
472 Fluid shear stress and atherosclerosis 💬
 1件: BMPR2 💬 D03779 💬 Dibotermin alfa 1件: 34 💬
473 Fluid shear stress and atherosclerosis 💬
 4件: CCL2, IL1A, IL1B, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
474 Fluid shear stress and atherosclerosis 💬
 1件: KDR 💬 D03218 💬 Axitinib 1件: 34 💬
475 Fluid shear stress and atherosclerosis 💬
 1件: KDR 💬 D10062 💬 Cabozantinib 1件: 34 💬
476 Fluid shear stress and atherosclerosis 💬
 1件: KDR 💬 D08881 💬 Cediranib 1件: 34 💬
477 Fluid shear stress and atherosclerosis 💬
 1件: KDR 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
478 Fluid shear stress and atherosclerosis 💬
 1件: KDR 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
479 Fluid shear stress and atherosclerosis 💬
 1件: KDR 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
480 Fluid shear stress and atherosclerosis 💬
 1件: KDR 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
481 Fluid shear stress and atherosclerosis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
482 Fluid shear stress and atherosclerosis 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
483 Fluid shear stress and atherosclerosis 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
484 Fluid shear stress and atherosclerosis 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
485 Focal adhesion 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
486 Focal adhesion 💬
 5件: BRAF, FLT4, KDR, PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
487 Focal adhesion 💬
 5件: BRAF, FLT4, KDR, PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
488 Focal adhesion 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
489 Focal adhesion 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
490 Focal adhesion 💬
 2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
491 Focal adhesion 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
492 Focal adhesion 💬
 3件: FLT1, FLT4, KDR 💬 D03218 💬 Axitinib 1件: 34 💬
493 Focal adhesion 💬
 3件: FLT1, FLT4, KDR 💬 D08881 💬 Cediranib 1件: 34 💬
494 Focal adhesion 💬
 5件: FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
495 Focal adhesion 💬
 5件: FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
496 Focal adhesion 💬
 2件: KDR, MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
497 Focal adhesion 💬
 1件: MAP2K1 💬 D10604 💬 Binimetinib 1件: 34 💬
498 Focal adhesion 💬
 1件: MAP2K1 💬 D09666 💬 Selumetinib 1件: 34 💬
499 Focal adhesion 💬
 1件: MAP2K1 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
500 Focal adhesion 💬
 1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
501 Focal adhesion 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
502 Focal adhesion 💬
 2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
503 Focal adhesion 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
504 Focal adhesion 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
505 Folate biosynthesis 💬
 2件: DHFR, DHFR2 💬 D00142 💬 Methotrexate 35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
506 Folate biosynthesis 💬
 2件: DHFR, DHFR2 💬 D02115 💬 Methotrexate 35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
507 FoxO signaling pathway 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
508 FoxO signaling pathway 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
509 FoxO signaling pathway 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
510 FoxO signaling pathway 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
511 FoxO signaling pathway 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
512 FoxO signaling pathway 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
513 FoxO signaling pathway 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
514 FoxO signaling pathway 💬
 2件: IL10, IL6 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
515 FoxO signaling pathway 💬
 1件: IL6 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
516 FoxO signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
517 FoxO signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
518 FoxO signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
519 GABAergic synapse 💬
 3件: ABAT, GAD1, GAD2 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
520 GABAergic synapse 💬
 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D00549 💬 Propofol 9件:  6 , 21, 22, 34, 46, 75, 84, 98, 296 💬
521 Gap junction 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
522 Gap junction 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
523 Gap junction 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
524 Gap junction 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
525 Gap junction 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
526 Gap junction 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
527 Gap junction 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
528 Gap junction 💬
 1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
529 Gap junction 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
530 Gap junction 💬
 2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
531 Gap junction 💬
 2件: PDGFRA, PDGFRB 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
532 Gap junction 💬
 2件: PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
533 Gap junction 💬
 2件: PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
534 Gap junction 💬
 2件: PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
535 Gap junction 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D01068 💬 Vinblastine 1件: 34 💬
536 Gap junction 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08675 💬 Vinblastine 1件: 34 💬
537 Gap junction 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D02197 💬 Vincristine 3件: 26, 34, 331 💬
538 Gap junction 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08679 💬 Vincristine 3件: 26, 34, 331 💬
539 Gastric cancer 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
540 Gastric cancer 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
541 Gastric cancer 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
542 Gastric cancer 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
543 Gastric cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
544 Gastric cancer 💬
 2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
545 Gastric cancer 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
546 Gastric cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
547 Gastric cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
548 Gastric cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
549 Gastric cancer 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
550 Gastric cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
551 Gastric cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
552 Gastric cancer 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
553 Glioma 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
554 Glioma 💬
 3件: BRAF, PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
555 Glioma 💬
 3件: BRAF, PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
556 Glioma 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
557 Glioma 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
558 Glioma 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
559 Glioma 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
560 Glioma 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
561 Glioma 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
562 Glioma 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
563 Glioma 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
564 Glioma 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
565 Glioma 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
566 Glioma 💬
 1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
567 Glioma 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
568 Glioma 💬
 2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
569 Glioma 💬
 2件: PDGFRA, PDGFRB 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
570 Glioma 💬
 2件: PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
571 GnRH secretion 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
572 GnRH secretion 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
573 GnRH secretion 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
574 GnRH secretion 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
575 GnRH secretion 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
576 GnRH secretion 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
577 GnRH signaling pathway 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
578 GnRH signaling pathway 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
579 GnRH signaling pathway 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
580 GnRH signaling pathway 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
581 GnRH signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
582 GnRH signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
583 GnRH signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
584 GnRH signaling pathway 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
585 GnRH signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
586 Graft-versus-host disease 💬
 4件: IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
587 Graft-versus-host disease 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
588 Graft-versus-host disease 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
589 Growth hormone synthesis, secretion and action 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
590 Growth hormone synthesis, secretion and action 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
591 Growth hormone synthesis, secretion and action 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
592 Growth hormone synthesis, secretion and action 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
593 Growth hormone synthesis, secretion and action 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
594 Growth hormone synthesis, secretion and action 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
595 Growth hormone synthesis, secretion and action 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
596 Growth hormone synthesis, secretion and action 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
597 Hematopoietic cell lineage 💬
 3件: CSF1, FLT3, KIT 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
598 Hematopoietic cell lineage 💬
 3件: CSF1, FLT3, KIT 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
599 Hematopoietic cell lineage 💬
 1件: CSF3R 💬 D03235 💬 Filgrastim 33件:  2 ,  6 , 11, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
600 Hematopoietic cell lineage 💬
 2件: FLT3, KIT 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
601 Hematopoietic cell lineage 💬
 2件: FLT3, KIT 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
602 Hematopoietic cell lineage 💬
 4件: IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
603 Hematopoietic cell lineage 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
604 Hematopoietic cell lineage 💬
 1件: KIT 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
605 Hematopoietic cell lineage 💬
 1件: KIT 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
606 Hematopoietic cell lineage 💬
 1件: KIT 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
607 Hematopoietic cell lineage 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
608 Hepatitis B 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
609 Hepatitis B 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
610 Hepatitis B 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
611 Hepatitis B 💬
 1件: IFNAR1 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
612 Hepatitis B 💬
 2件: IL6, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
613 Hepatitis B 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
614 Hepatitis B 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
615 Hepatitis B 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
616 Hepatitis B 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
617 Hepatitis B 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
618 Hepatitis C 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
619 Hepatitis C 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
620 Hepatitis C 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
621 Hepatitis C 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
622 Hepatitis C 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
623 Hepatitis C 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
624 Hepatitis C 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
625 Hepatitis C 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
626 Hepatitis C 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
627 Hepatitis C 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
628 Hepatitis C 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
629 Hepatitis C 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
630 Hepatitis C 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
631 Hepatitis C 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
632 Hepatocellular carcinoma 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
633 Hepatocellular carcinoma 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
634 Hepatocellular carcinoma 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
635 Hepatocellular carcinoma 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
636 Hepatocellular carcinoma 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
637 Hepatocellular carcinoma 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
638 Hepatocellular carcinoma 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
639 Hepatocellular carcinoma 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
640 Hepatocellular carcinoma 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
641 Hepatocellular carcinoma 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
642 Hepatocellular carcinoma 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
643 Hepatocellular carcinoma 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
644 Hepatocellular carcinoma 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
645 Hepatocellular carcinoma 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
646 Herpes simplex virus 1 infection 💬
 4件: CCL2, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
647 Herpes simplex virus 1 infection 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
648 Herpes simplex virus 1 infection 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
649 Herpes simplex virus 1 infection 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
650 Herpes simplex virus 1 infection 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
651 Herpes simplex virus 1 infection 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
652 Herpes simplex virus 1 infection 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
653 HIF-1 signaling pathway 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
654 HIF-1 signaling pathway 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
655 HIF-1 signaling pathway 💬
 2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
656 HIF-1 signaling pathway 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
657 HIF-1 signaling pathway 💬
 1件: FLT1 💬 D03218 💬 Axitinib 1件: 34 💬
658 HIF-1 signaling pathway 💬
 1件: FLT1 💬 D08881 💬 Cediranib 1件: 34 💬
659 HIF-1 signaling pathway 💬
 1件: FLT1 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
660 HIF-1 signaling pathway 💬
 1件: FLT1 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
661 HIF-1 signaling pathway 💬
 1件: IL6 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
662 HIF-1 signaling pathway 💬
 1件: IL6 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
663 HIF-1 signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
664 HIF-1 signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
665 HIF-1 signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
666 HIF-1 signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
667 HIF-1 signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
668 HIF-1 signaling pathway 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
669 HIF-1 signaling pathway 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
670 HIF-1 signaling pathway 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
671 Hippo signaling pathway 💬
 1件: BMPR2 💬 D03779 💬 Dibotermin alfa 1件: 34 💬
672 Human cytomegalovirus infection 💬
 4件: CCL2, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
673 Human cytomegalovirus infection 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
674 Human cytomegalovirus infection 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
675 Human cytomegalovirus infection 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
676 Human cytomegalovirus infection 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
677 Human cytomegalovirus infection 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
678 Human cytomegalovirus infection 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
679 Human cytomegalovirus infection 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
680 Human cytomegalovirus infection 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
681 Human cytomegalovirus infection 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
682 Human cytomegalovirus infection 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
683 Human cytomegalovirus infection 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
684 Human cytomegalovirus infection 💬
 1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
685 Human cytomegalovirus infection 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
686 Human cytomegalovirus infection 💬
 1件: PDGFRA 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
687 Human cytomegalovirus infection 💬
 1件: PDGFRA 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
688 Human cytomegalovirus infection 💬
 1件: PDGFRA 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
689 Human cytomegalovirus infection 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 16件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
690 Human cytomegalovirus infection 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 14件: 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
691 Human cytomegalovirus infection 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 9件:  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
692 Human cytomegalovirus infection 💬
 1件: PTGS2 💬 D00903 💬 Diclofenac 4件: 13, 34, 46, 271 💬
693 Human cytomegalovirus infection 💬
 1件: PTGS2 💬 D00904 💬 Diclofenac 4件: 13, 34, 46, 271 💬
694 Human cytomegalovirus infection 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 4件: 13, 34, 46, 271 💬
695 Human cytomegalovirus infection 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
696 Human cytomegalovirus infection 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
697 Human cytomegalovirus infection 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
698 Human cytomegalovirus infection 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
699 Human cytomegalovirus infection 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
700 Human immunodeficiency virus 1 infection 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
701 Human immunodeficiency virus 1 infection 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
702 Human immunodeficiency virus 1 infection 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
703 Human immunodeficiency virus 1 infection 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
704 Human immunodeficiency virus 1 infection 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
705 Human immunodeficiency virus 1 infection 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
706 Human immunodeficiency virus 1 infection 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
707 Human immunodeficiency virus 1 infection 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
708 Human immunodeficiency virus 1 infection 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
709 Human immunodeficiency virus 1 infection 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
710 Human immunodeficiency virus 1 infection 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
711 Human papillomavirus infection 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
712 Human papillomavirus infection 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
713 Human papillomavirus infection 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
714 Human papillomavirus infection 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
715 Human papillomavirus infection 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
716 Human papillomavirus infection 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
717 Human papillomavirus infection 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
718 Human papillomavirus infection 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
719 Human papillomavirus infection 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
720 Human papillomavirus infection 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
721 Human papillomavirus infection 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
722 Human papillomavirus infection 💬
 1件: PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
723 Human papillomavirus infection 💬
 1件: PDGFRB 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
724 Human papillomavirus infection 💬
 1件: PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
725 Human papillomavirus infection 💬
 2件: PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
726 Human papillomavirus infection 💬
 2件: PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
727 Human papillomavirus infection 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 16件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
728 Human papillomavirus infection 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 14件: 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
729 Human papillomavirus infection 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 9件:  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
730 Human papillomavirus infection 💬
 1件: PTGS2 💬 D00903 💬 Diclofenac 4件: 13, 34, 46, 271 💬
731 Human papillomavirus infection 💬
 1件: PTGS2 💬 D00904 💬 Diclofenac 4件: 13, 34, 46, 271 💬
732 Human papillomavirus infection 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 4件: 13, 34, 46, 271 💬
733 Human papillomavirus infection 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
734 Human papillomavirus infection 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
735 Human papillomavirus infection 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
736 Human papillomavirus infection 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
737 Human papillomavirus infection 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
738 Human T-cell leukemia virus 1 infection 💬
 2件: IL6, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
739 Human T-cell leukemia virus 1 infection 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
740 Human T-cell leukemia virus 1 infection 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
741 Human T-cell leukemia virus 1 infection 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
742 Human T-cell leukemia virus 1 infection 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
743 Human T-cell leukemia virus 1 infection 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
744 Huntington disease 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
745 Huntington disease 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
746 Huntington disease 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
747 Huntington disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D01068 💬 Vinblastine 1件: 34 💬
748 Huntington disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08675 💬 Vinblastine 1件: 34 💬
749 Huntington disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D02197 💬 Vincristine 3件: 26, 34, 331 💬
750 Huntington disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08679 💬 Vincristine 3件: 26, 34, 331 💬
751 Hypertrophic cardiomyopathy 💬
 2件: IL6, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
752 Hypertrophic cardiomyopathy 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
753 Hypertrophic cardiomyopathy 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
754 IL-17 signaling pathway 💬
 4件: CCL2, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
755 IL-17 signaling pathway 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
756 IL-17 signaling pathway 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 16件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
757 IL-17 signaling pathway 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 14件: 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
758 IL-17 signaling pathway 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 9件:  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
759 IL-17 signaling pathway 💬
 1件: PTGS2 💬 D00903 💬 Diclofenac 4件: 13, 34, 46, 271 💬
760 IL-17 signaling pathway 💬
 1件: PTGS2 💬 D00904 💬 Diclofenac 4件: 13, 34, 46, 271 💬
761 IL-17 signaling pathway 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 4件: 13, 34, 46, 271 💬
762 IL-17 signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
763 Inflammatory bowel disease 💬
 5件: IL10, IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
764 Inflammatory bowel disease 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
765 Inflammatory bowel disease 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
766 Inflammatory mediator regulation of TRP channels 💬
 1件: IL1B 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
767 Influenza A 💬
 5件: CCL2, IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
768 Influenza A 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
769 Influenza A 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
770 Influenza A 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
771 Influenza A 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
772 Influenza A 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
773 Influenza A 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
774 Influenza A 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
775 Influenza A 💬
 1件: TLR7 💬 D02500 💬 Imiquimod 2件: 34, 51 💬
776 Influenza A 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
777 Insulin resistance 💬
 2件: IL6, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
778 Insulin resistance 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
779 Insulin resistance 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
780 Insulin resistance 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
781 Insulin resistance 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
782 Insulin resistance 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
783 Insulin signaling pathway 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
784 Insulin signaling pathway 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
785 Insulin signaling pathway 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
786 Insulin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
787 Insulin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
788 Insulin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
789 Insulin signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
790 Insulin signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
791 Insulin signaling pathway 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
792 Intestinal immune network for IgA production 💬
 2件: IL10, IL6 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
793 Intestinal immune network for IgA production 💬
 1件: IL6 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
794 JAK-STAT signaling pathway 💬
 1件: CSF3R 💬 D03235 💬 Filgrastim 33件:  2 ,  6 , 11, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
795 JAK-STAT signaling pathway 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
796 JAK-STAT signaling pathway 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
797 JAK-STAT signaling pathway 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
798 JAK-STAT signaling pathway 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
799 JAK-STAT signaling pathway 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
800 JAK-STAT signaling pathway 💬
 2件: IL10, IL6 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
801 JAK-STAT signaling pathway 💬
 1件: IL6 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
802 JAK-STAT signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
803 JAK-STAT signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
804 JAK-STAT signaling pathway 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
805 JAK-STAT signaling pathway 💬
 1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
806 JAK-STAT signaling pathway 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
807 JAK-STAT signaling pathway 💬
 2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
808 JAK-STAT signaling pathway 💬
 2件: PDGFRA, PDGFRB 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
809 JAK-STAT signaling pathway 💬
 2件: PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
810 JAK-STAT signaling pathway 💬
 2件: PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
811 JAK-STAT signaling pathway 💬
 2件: PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
812 Kaposi sarcoma-associated herpesvirus infection 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
813 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: IL6 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
814 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: IL6 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
815 Kaposi sarcoma-associated herpesvirus infection 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
816 Kaposi sarcoma-associated herpesvirus infection 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
817 Kaposi sarcoma-associated herpesvirus infection 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
818 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
819 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
820 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
821 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 16件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
822 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 14件: 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
823 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 9件:  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
824 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: PTGS2 💬 D00903 💬 Diclofenac 4件: 13, 34, 46, 271 💬
825 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: PTGS2 💬 D00904 💬 Diclofenac 4件: 13, 34, 46, 271 💬
826 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 4件: 13, 34, 46, 271 💬
827 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
828 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
829 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
830 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
831 Legionellosis 💬
 3件: IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
832 Legionellosis 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
833 Legionellosis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
834 Leishmaniasis 💬
 4件: IL10, IL1A, IL1B, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
835 Leishmaniasis 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 16件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
836 Leishmaniasis 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 14件: 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
837 Leishmaniasis 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 9件:  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
838 Leishmaniasis 💬
 1件: PTGS2 💬 D00903 💬 Diclofenac 4件: 13, 34, 46, 271 💬
839 Leishmaniasis 💬
 1件: PTGS2 💬 D00904 💬 Diclofenac 4件: 13, 34, 46, 271 💬
840 Leishmaniasis 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 4件: 13, 34, 46, 271 💬
841 Leishmaniasis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
842 Leishmaniasis 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
843 Long-term depression 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
844 Long-term depression 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
845 Long-term depression 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
846 Long-term depression 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
847 Long-term depression 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
848 Long-term depression 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
849 Long-term potentiation 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
850 Long-term potentiation 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
851 Long-term potentiation 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
852 Long-term potentiation 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
853 Long-term potentiation 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
854 Long-term potentiation 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
855 Longevity regulating pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
856 Longevity regulating pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
857 Longevity regulating pathway 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
858 Longevity regulating pathway - multiple species 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
859 Longevity regulating pathway - multiple species 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
860 Longevity regulating pathway - multiple species 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
861 Malaria 💬
 5件: CCL2, IL10, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
862 Malaria 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
863 Malaria 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
864 Malaria 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
865 MAPK signaling pathway 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
866 MAPK signaling pathway 💬
 7件: BRAF, FLT3, FLT4, KDR, KIT, PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
867 MAPK signaling pathway 💬
 7件: BRAF, FLT3, FLT4, KDR, KIT, PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
868 MAPK signaling pathway 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
869 MAPK signaling pathway 💬
 8件: CSF1, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
870 MAPK signaling pathway 💬
 8件: CSF1, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
871 MAPK signaling pathway 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
872 MAPK signaling pathway 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
873 MAPK signaling pathway 💬
 2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
874 MAPK signaling pathway 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
875 MAPK signaling pathway 💬
 3件: FLT1, FLT4, KDR 💬 D03218 💬 Axitinib 1件: 34 💬
876 MAPK signaling pathway 💬
 3件: FLT1, FLT4, KDR 💬 D08881 💬 Cediranib 1件: 34 💬
877 MAPK signaling pathway 💬
 3件: IL1A, IL1B, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
878 MAPK signaling pathway 💬
 2件: KDR, MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
879 MAPK signaling pathway 💬
 2件: KIT, PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
880 MAPK signaling pathway 💬
 2件: KIT, PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
881 MAPK signaling pathway 💬
 3件: KIT, PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
882 MAPK signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
883 MAPK signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
884 MAPK signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
885 MAPK signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
886 MAPK signaling pathway 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
887 MAPK signaling pathway 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
888 MAPK signaling pathway 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
889 Measles 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
890 Measles 💬
 3件: IL1A, IL1B, IL6 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
891 Measles 💬
 1件: IL6 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
892 Measles 💬
 1件: TLR7 💬 D02500 💬 Imiquimod 2件: 34, 51 💬
893 Melanogenesis 💬
 1件: KIT 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
894 Melanogenesis 💬
 1件: KIT 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
895 Melanogenesis 💬
 1件: KIT 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
896 Melanogenesis 💬
 1件: KIT 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
897 Melanogenesis 💬
 1件: KIT 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
898 Melanogenesis 💬
 2件: KIT, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
899 Melanogenesis 💬
 2件: KIT, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
900 Melanogenesis 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
901 Melanogenesis 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
902 Melanogenesis 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
903 Melanoma 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
904 Melanoma 💬
 3件: BRAF, PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
905 Melanoma 💬
 3件: BRAF, PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
906 Melanoma 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
907 Melanoma 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
908 Melanoma 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
909 Melanoma 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
910 Melanoma 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
911 Melanoma 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
912 Melanoma 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
913 Melanoma 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
914 Melanoma 💬
 1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
915 Melanoma 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
916 Melanoma 💬
 2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
917 Melanoma 💬
 2件: PDGFRA, PDGFRB 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
918 Melanoma 💬
 2件: PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
919 Metabolic pathways 💬
 4件: ABAT, ALDH5A1, GAD1, GAD2 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
920 Metabolic pathways 💬
 2件: DHFR, DHFR2 💬 D00142 💬 Methotrexate 35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
921 Metabolic pathways 💬
 2件: DHFR, DHFR2 💬 D02115 💬 Methotrexate 35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
922 Metabolic pathways 💬
 1件: HMGCR 💬 D00359 💬 Lovastatin 11件:  6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
923 Metabolic pathways 💬
 1件: HMGCR 💬 D00434 💬 Simvastatin 21件:  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
924 Metabolic pathways 💬
 2件: PTGS1, PTGS2 💬 D00217 💬 Acetaminophen 16件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
925 Metabolic pathways 💬
 2件: PTGS1, PTGS2 💬 D00109 💬 Acetylsalicylic acid 14件: 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
926 Metabolic pathways 💬
 2件: PTGS1, PTGS2 💬 D00903 💬 Diclofenac 4件: 13, 34, 46, 271 💬
927 Metabolic pathways 💬
 2件: PTGS1, PTGS2 💬 D00904 💬 Diclofenac 4件: 13, 34, 46, 271 💬
928 Metabolic pathways 💬
 2件: PTGS1, PTGS2 💬 D07816 💬 Diclofenac 4件: 13, 34, 46, 271 💬
929 Metabolic pathways 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 9件:  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
930 MicroRNAs in cancer 💬
 2件: ABL1, PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
931 MicroRNAs in cancer 💬
 2件: ABL1, PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
932 MicroRNAs in cancer 💬
 3件: ABL1, PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
933 MicroRNAs in cancer 💬
 1件: BMPR2 💬 D03779 💬 Dibotermin alfa 1件: 34 💬
934 MicroRNAs in cancer 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
935 MicroRNAs in cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
936 MicroRNAs in cancer 💬
 2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
937 MicroRNAs in cancer 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
938 MicroRNAs in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
939 MicroRNAs in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
940 MicroRNAs in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
941 MicroRNAs in cancer 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
942 MicroRNAs in cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
943 MicroRNAs in cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
944 MicroRNAs in cancer 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
945 MicroRNAs in cancer 💬
 2件: PDGFRA, PDGFRB 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
946 MicroRNAs in cancer 💬
 2件: PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
947 MicroRNAs in cancer 💬
 2件: PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
948 MicroRNAs in cancer 💬
 2件: PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
949 MicroRNAs in cancer 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 16件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
950 MicroRNAs in cancer 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 14件: 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
951 MicroRNAs in cancer 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 9件:  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
952 MicroRNAs in cancer 💬
 1件: PTGS2 💬 D00903 💬 Diclofenac 4件: 13, 34, 46, 271 💬
953 MicroRNAs in cancer 💬
 1件: PTGS2 💬 D00904 💬 Diclofenac 4件: 13, 34, 46, 271 💬
954 MicroRNAs in cancer 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 4件: 13, 34, 46, 271 💬
955 MicroRNAs in cancer 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
956 MicroRNAs in cancer 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
957 Mineral absorption 💬
 1件: VDR 💬 D00188 💬 Cholecalciferol 23件:  6 , 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 84, 85, 96, 97, 162, 202, 228, 271, 298, 299 💬
958 Morphine addiction 💬
 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D00549 💬 Propofol 9件:  6 , 21, 22, 34, 46, 75, 84, 98, 296 💬
959 mTOR signaling pathway 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
960 mTOR signaling pathway 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
961 mTOR signaling pathway 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
962 mTOR signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
963 mTOR signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
964 mTOR signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
965 mTOR signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
966 mTOR signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
967 mTOR signaling pathway 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
968 mTOR signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
969 mTOR signaling pathway 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
970 mTOR signaling pathway 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
971 Natural killer cell mediated cytotoxicity 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
972 Natural killer cell mediated cytotoxicity 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
973 Natural killer cell mediated cytotoxicity 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
974 Natural killer cell mediated cytotoxicity 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
975 Natural killer cell mediated cytotoxicity 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
976 Natural killer cell mediated cytotoxicity 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
977 Natural killer cell mediated cytotoxicity 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
978 Natural killer cell mediated cytotoxicity 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
979 Natural killer cell mediated cytotoxicity 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
980 Natural killer cell mediated cytotoxicity 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
981 Necroptosis 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
982 Necroptosis 💬
 3件: IL1A, IL1B, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
983 Necroptosis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
984 Necroptosis 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
985 Neuroactive ligand-receptor interaction 💬
 3件: ADRA2A, ADRA2B, ADRA2C 💬 D00514 💬 Dexmedetomidine 12件:  2 ,  4 ,  6 , 21, 34, 46, 70, 113, 212, 215, 226, 280 💬
986 Neuroactive ligand-receptor interaction 💬
 3件: ADRA2A, ADRA2B, ADRA2C 💬 D01205 💬 Dexmedetomidine 12件:  2 ,  4 ,  6 , 21, 34, 46, 70, 113, 212, 215, 226, 280 💬
987 Neuroactive ligand-receptor interaction 💬
 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D00549 💬 Propofol 9件:  6 , 21, 22, 34, 46, 75, 84, 98, 296 💬
988 Neurotrophin signaling pathway 💬
 1件: ABL1 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
989 Neurotrophin signaling pathway 💬
 1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
990 Neurotrophin signaling pathway 💬
 1件: ABL1 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
991 Neurotrophin signaling pathway 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
992 Neurotrophin signaling pathway 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
993 Neurotrophin signaling pathway 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
994 Neurotrophin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
995 Neurotrophin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
996 Neurotrophin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
997 Neutrophil extracellular trap formation 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
998 Neutrophil extracellular trap formation 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
999 Neutrophil extracellular trap formation 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1000 Neutrophil extracellular trap formation 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1001 Neutrophil extracellular trap formation 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1002 Neutrophil extracellular trap formation 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1003 Neutrophil extracellular trap formation 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1004 Neutrophil extracellular trap formation 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1005 Neutrophil extracellular trap formation 💬
 1件: TLR7 💬 D02500 💬 Imiquimod 2件: 34, 51 💬
1006 NF-kappa B signaling pathway 💬
 2件: IL1B, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1007 NF-kappa B signaling pathway 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 16件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
1008 NF-kappa B signaling pathway 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 14件: 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
1009 NF-kappa B signaling pathway 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 9件:  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
1010 NF-kappa B signaling pathway 💬
 1件: PTGS2 💬 D00903 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1011 NF-kappa B signaling pathway 💬
 1件: PTGS2 💬 D00904 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1012 NF-kappa B signaling pathway 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1013 NF-kappa B signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
1014 NF-kappa B signaling pathway 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1015 Nicotine addiction 💬
 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D00549 💬 Propofol 9件:  6 , 21, 22, 34, 46, 75, 84, 98, 296 💬
1016 NOD-like receptor signaling pathway 💬
 4件: CCL2, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1017 NOD-like receptor signaling pathway 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
1018 NOD-like receptor signaling pathway 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1019 NOD-like receptor signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
1020 Non-alcoholic fatty liver disease 💬
 4件: IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1021 Non-alcoholic fatty liver disease 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1022 Non-alcoholic fatty liver disease 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
1023 Non-small cell lung cancer 💬
 1件: ALK 💬 D10866 💬 Brigatinib 1件: 34 💬
1024 Non-small cell lung cancer 💬
 1件: ALK 💬 D09731 💬 Crizotinib 1件: 34 💬
1025 Non-small cell lung cancer 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
1026 Non-small cell lung cancer 💬
 3件: BRAF, RAF1, RET 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1027 Non-small cell lung cancer 💬
 3件: BRAF, RAF1, RET 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1028 Non-small cell lung cancer 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1029 Non-small cell lung cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
1030 Non-small cell lung cancer 💬
 2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
1031 Non-small cell lung cancer 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
1032 Non-small cell lung cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1033 Non-small cell lung cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1034 Non-small cell lung cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1035 Non-small cell lung cancer 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
1036 Non-small cell lung cancer 💬
 1件: RET 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
1037 Non-small cell lung cancer 💬
 1件: RET 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
1038 One carbon pool by folate 💬
 2件: DHFR, DHFR2 💬 D00142 💬 Methotrexate 35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
1039 One carbon pool by folate 💬
 2件: DHFR, DHFR2 💬 D02115 💬 Methotrexate 35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
1040 Oocyte meiosis 💬
 1件: MAP2K1 💬 D10604 💬 Binimetinib 1件: 34 💬
1041 Oocyte meiosis 💬
 1件: MAP2K1 💬 D09666 💬 Selumetinib 1件: 34 💬
1042 Oocyte meiosis 💬
 1件: MAP2K1 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1043 Osteoclast differentiation 💬
 1件: CSF1 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
1044 Osteoclast differentiation 💬
 1件: CSF1 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
1045 Osteoclast differentiation 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
1046 Osteoclast differentiation 💬
 3件: IL1A, IL1B, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1047 Osteoclast differentiation 💬
 1件: MAP2K1 💬 D10604 💬 Binimetinib 1件: 34 💬
1048 Osteoclast differentiation 💬
 1件: MAP2K1 💬 D09666 💬 Selumetinib 1件: 34 💬
1049 Osteoclast differentiation 💬
 1件: MAP2K1 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1050 Osteoclast differentiation 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
1051 Osteoclast differentiation 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1052 Ovarian steroidogenesis 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 16件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
1053 Ovarian steroidogenesis 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 14件: 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
1054 Ovarian steroidogenesis 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 9件:  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
1055 Ovarian steroidogenesis 💬
 1件: PTGS2 💬 D00903 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1056 Ovarian steroidogenesis 💬
 1件: PTGS2 💬 D00904 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1057 Ovarian steroidogenesis 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1058 Oxytocin signaling pathway 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1059 Oxytocin signaling pathway 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
1060 Oxytocin signaling pathway 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
1061 Oxytocin signaling pathway 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
1062 Oxytocin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1063 Oxytocin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1064 Oxytocin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1065 Oxytocin signaling pathway 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 16件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
1066 Oxytocin signaling pathway 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 14件: 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
1067 Oxytocin signaling pathway 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 9件:  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
1068 Oxytocin signaling pathway 💬
 1件: PTGS2 💬 D00903 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1069 Oxytocin signaling pathway 💬
 1件: PTGS2 💬 D00904 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1070 Oxytocin signaling pathway 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1071 Oxytocin signaling pathway 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1072 Oxytocin signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1073 Pancreatic cancer 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
1074 Pancreatic cancer 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1075 Pancreatic cancer 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1076 Pancreatic cancer 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1077 Pancreatic cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
1078 Pancreatic cancer 💬
 2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
1079 Pancreatic cancer 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
1080 Pancreatic cancer 💬
 1件: MAP2K1 💬 D10604 💬 Binimetinib 1件: 34 💬
1081 Pancreatic cancer 💬
 1件: MAP2K1 💬 D09666 💬 Selumetinib 1件: 34 💬
1082 Pancreatic cancer 💬
 1件: MAP2K1 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1083 Pancreatic cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1084 Pancreatic cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1085 Pancreatic cancer 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1086 Pancreatic cancer 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1087 Pancreatic cancer 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1088 Parathyroid hormone synthesis, secretion and action 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
1089 Parathyroid hormone synthesis, secretion and action 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1090 Parathyroid hormone synthesis, secretion and action 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1091 Parathyroid hormone synthesis, secretion and action 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1092 Parathyroid hormone synthesis, secretion and action 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
1093 Parathyroid hormone synthesis, secretion and action 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
1094 Parathyroid hormone synthesis, secretion and action 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
1095 Parathyroid hormone synthesis, secretion and action 💬
 1件: MAP2K1 💬 D10604 💬 Binimetinib 1件: 34 💬
1096 Parathyroid hormone synthesis, secretion and action 💬
 1件: MAP2K1 💬 D09666 💬 Selumetinib 1件: 34 💬
1097 Parathyroid hormone synthesis, secretion and action 💬
 1件: MAP2K1 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1098 Parathyroid hormone synthesis, secretion and action 💬
 1件: VDR 💬 D00188 💬 Cholecalciferol 23件:  6 , 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 84, 85, 96, 97, 162, 202, 228, 271, 298, 299 💬
1099 Parkinson disease 💬
 1件: SLC6A3 💬 D01296 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
1100 Parkinson disease 💬
 1件: SLC6A3 💬 D04999 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
1101 Parkinson disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D01068 💬 Vinblastine 1件: 34 💬
1102 Parkinson disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08675 💬 Vinblastine 1件: 34 💬
1103 Parkinson disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D02197 💬 Vincristine 3件: 26, 34, 331 💬
1104 Parkinson disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08679 💬 Vincristine 3件: 26, 34, 331 💬
1105 Pathogenic Escherichia coli infection 💬
 1件: ABL1 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1106 Pathogenic Escherichia coli infection 💬
 1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1107 Pathogenic Escherichia coli infection 💬
 1件: ABL1 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1108 Pathogenic Escherichia coli infection 💬
 3件: IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1109 Pathogenic Escherichia coli infection 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1110 Pathogenic Escherichia coli infection 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
1111 Pathogenic Escherichia coli infection 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D01068 💬 Vinblastine 1件: 34 💬
1112 Pathogenic Escherichia coli infection 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08675 💬 Vinblastine 1件: 34 💬
1113 Pathogenic Escherichia coli infection 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D02197 💬 Vincristine 3件: 26, 34, 331 💬
1114 Pathogenic Escherichia coli infection 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08679 💬 Vincristine 3件: 26, 34, 331 💬
1115 Pathways in cancer 💬
 3件: ABL1, KIT, PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1116 Pathways in cancer 💬
 3件: ABL1, KIT, PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1117 Pathways in cancer 💬
 4件: ABL1, KIT, PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1118 Pathways in cancer 💬
 1件: ALK 💬 D10866 💬 Brigatinib 1件: 34 💬
1119 Pathways in cancer 💬
 1件: ALK 💬 D09731 💬 Crizotinib 1件: 34 💬
1120 Pathways in cancer 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
1121 Pathways in cancer 💬
 7件: BRAF, FLT3, FLT4, KIT, PDGFRB, RAF1, RET 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1122 Pathways in cancer 💬
 7件: BRAF, FLT3, FLT4, KIT, PDGFRB, RAF1, RET 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1123 Pathways in cancer 💬
 1件: CSF3R 💬 D03235 💬 Filgrastim 33件:  2 ,  6 , 11, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
1124 Pathways in cancer 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1125 Pathways in cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
1126 Pathways in cancer 💬
 2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
1127 Pathways in cancer 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
1128 Pathways in cancer 💬
 6件: FLT3, FLT4, KIT, PDGFRA, PDGFRB, RET 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
1129 Pathways in cancer 💬
 6件: FLT3, FLT4, KIT, PDGFRA, PDGFRB, RET 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
1130 Pathways in cancer 💬
 1件: FLT4 💬 D03218 💬 Axitinib 1件: 34 💬
1131 Pathways in cancer 💬
 1件: FLT4 💬 D08881 💬 Cediranib 1件: 34 💬
1132 Pathways in cancer 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
1133 Pathways in cancer 💬
 1件: IL6 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1134 Pathways in cancer 💬
 1件: IL6 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1135 Pathways in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1136 Pathways in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1137 Pathways in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1138 Pathways in cancer 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
1139 Pathways in cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1140 Pathways in cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1141 Pathways in cancer 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1142 Pathways in cancer 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 16件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
1143 Pathways in cancer 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 14件: 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
1144 Pathways in cancer 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 9件:  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
1145 Pathways in cancer 💬
 1件: PTGS2 💬 D00903 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1146 Pathways in cancer 💬
 1件: PTGS2 💬 D00904 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1147 Pathways in cancer 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1148 Pathways in cancer 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1149 Pathways in cancer 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1150 Pathways of neurodegeneration - multiple diseases 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
1151 Pathways of neurodegeneration - multiple diseases 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1152 Pathways of neurodegeneration - multiple diseases 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1153 Pathways of neurodegeneration - multiple diseases 💬
 1件: CSF1 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
1154 Pathways of neurodegeneration - multiple diseases 💬
 1件: CSF1 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
1155 Pathways of neurodegeneration - multiple diseases 💬
 4件: IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1156 Pathways of neurodegeneration - multiple diseases 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1157 Pathways of neurodegeneration - multiple diseases 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1158 Pathways of neurodegeneration - multiple diseases 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1159 Pathways of neurodegeneration - multiple diseases 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1160 Pathways of neurodegeneration - multiple diseases 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1161 Pathways of neurodegeneration - multiple diseases 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1162 Pathways of neurodegeneration - multiple diseases 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1163 Pathways of neurodegeneration - multiple diseases 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 16件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
1164 Pathways of neurodegeneration - multiple diseases 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 14件: 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
1165 Pathways of neurodegeneration - multiple diseases 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 9件:  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
1166 Pathways of neurodegeneration - multiple diseases 💬
 1件: PTGS2 💬 D00903 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1167 Pathways of neurodegeneration - multiple diseases 💬
 1件: PTGS2 💬 D00904 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1168 Pathways of neurodegeneration - multiple diseases 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1169 Pathways of neurodegeneration - multiple diseases 💬
 1件: SLC6A3 💬 D01296 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
1170 Pathways of neurodegeneration - multiple diseases 💬
 1件: SLC6A3 💬 D04999 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
1171 Pathways of neurodegeneration - multiple diseases 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
1172 Pathways of neurodegeneration - multiple diseases 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D01068 💬 Vinblastine 1件: 34 💬
1173 Pathways of neurodegeneration - multiple diseases 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08675 💬 Vinblastine 1件: 34 💬
1174 Pathways of neurodegeneration - multiple diseases 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D02197 💬 Vincristine 3件: 26, 34, 331 💬
1175 Pathways of neurodegeneration - multiple diseases 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08679 💬 Vincristine 3件: 26, 34, 331 💬
1176 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: ALK 💬 D10866 💬 Brigatinib 1件: 34 💬
1177 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: ALK 💬 D09731 💬 Crizotinib 1件: 34 💬
1178 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1179 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
1180 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
1181 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
1182 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1183 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1184 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1185 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1186 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1187 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1188 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1189 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1190 Pertussis 💬
 5件: IL10, IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1191 Pertussis 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1192 Pertussis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
1193 Phagosome 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D01068 💬 Vinblastine 1件: 34 💬
1194 Phagosome 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08675 💬 Vinblastine 1件: 34 💬
1195 Phagosome 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D02197 💬 Vincristine 3件: 26, 34, 331 💬
1196 Phagosome 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08679 💬 Vincristine 3件: 26, 34, 331 💬
1197 Phospholipase D signaling pathway 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1198 Phospholipase D signaling pathway 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
1199 Phospholipase D signaling pathway 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
1200 Phospholipase D signaling pathway 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
1201 Phospholipase D signaling pathway 💬
 2件: KIT, PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1202 Phospholipase D signaling pathway 💬
 2件: KIT, PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1203 Phospholipase D signaling pathway 💬
 3件: KIT, PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1204 Phospholipase D signaling pathway 💬
 3件: KIT, PDGFRA, PDGFRB 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
1205 Phospholipase D signaling pathway 💬
 3件: KIT, PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
1206 Phospholipase D signaling pathway 💬
 3件: KIT, PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1207 Phospholipase D signaling pathway 💬
 3件: KIT, PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1208 Phospholipase D signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1209 Phospholipase D signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1210 Phospholipase D signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1211 Phospholipase D signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1212 Phospholipase D signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1213 Phospholipase D signaling pathway 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1214 PI3K-Akt signaling pathway 💬
 8件: CSF1, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
1215 PI3K-Akt signaling pathway 💬
 8件: CSF1, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
1216 PI3K-Akt signaling pathway 💬
 1件: CSF3R 💬 D03235 💬 Filgrastim 33件:  2 ,  6 , 11, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
1217 PI3K-Akt signaling pathway 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1218 PI3K-Akt signaling pathway 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
1219 PI3K-Akt signaling pathway 💬
 2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
1220 PI3K-Akt signaling pathway 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
1221 PI3K-Akt signaling pathway 💬
 3件: FLT1, FLT4, KDR 💬 D03218 💬 Axitinib 1件: 34 💬
1222 PI3K-Akt signaling pathway 💬
 3件: FLT1, FLT4, KDR 💬 D08881 💬 Cediranib 1件: 34 💬
1223 PI3K-Akt signaling pathway 💬
 6件: FLT3, FLT4, KDR, KIT, PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1224 PI3K-Akt signaling pathway 💬
 6件: FLT3, FLT4, KDR, KIT, PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1225 PI3K-Akt signaling pathway 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
1226 PI3K-Akt signaling pathway 💬
 1件: IL6 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1227 PI3K-Akt signaling pathway 💬
 1件: IL6 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1228 PI3K-Akt signaling pathway 💬
 2件: KDR, MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
1229 PI3K-Akt signaling pathway 💬
 2件: KIT, PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1230 PI3K-Akt signaling pathway 💬
 2件: KIT, PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1231 PI3K-Akt signaling pathway 💬
 3件: KIT, PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1232 PI3K-Akt signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1233 PI3K-Akt signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1234 PI3K-Akt signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1235 PI3K-Akt signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1236 PI3K-Akt signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1237 PI3K-Akt signaling pathway 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1238 PI3K-Akt signaling pathway 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1239 PI3K-Akt signaling pathway 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1240 Platelet activation 💬
 1件: PTGS1 💬 D00217 💬 Acetaminophen 16件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
1241 Platelet activation 💬
 1件: PTGS1 💬 D00109 💬 Acetylsalicylic acid 14件: 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
1242 Platelet activation 💬
 1件: PTGS1 💬 D00903 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1243 Platelet activation 💬
 1件: PTGS1 💬 D00904 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1244 Platelet activation 💬
 1件: PTGS1 💬 D07816 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1245 Platinum drug resistance 💬
 1件: ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
1246 Platinum drug resistance 💬
 1件: ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
1247 Platinum drug resistance 💬
 2件: TOP2A, TOP2B 💬 D03899 💬 Doxorubicin 4件: 26, 28, 34, 331 💬
1248 Platinum drug resistance 💬
 2件: TOP2A, TOP2B 💬 D00125 💬 Etoposide 11件: 11, 13, 14, 26, 28, 34, 60, 65, 85, 164, 331 💬
1249 Platinum drug resistance 💬
 2件: TOP2A, TOP2B 💬 D04107 💬 Etoposide 11件: 11, 13, 14, 26, 28, 34, 60, 65, 85, 164, 331 💬
1250 Prion disease 💬
 4件: IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1251 Prion disease 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1252 Prion disease 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
1253 Prion disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D01068 💬 Vinblastine 1件: 34 💬
1254 Prion disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08675 💬 Vinblastine 1件: 34 💬
1255 Prion disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D02197 💬 Vincristine 3件: 26, 34, 331 💬
1256 Prion disease 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08679 💬 Vincristine 3件: 26, 34, 331 💬
1257 Progesterone-mediated oocyte maturation 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
1258 Progesterone-mediated oocyte maturation 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1259 Progesterone-mediated oocyte maturation 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1260 Progesterone-mediated oocyte maturation 💬
 1件: MAP2K1 💬 D10604 💬 Binimetinib 1件: 34 💬
1261 Progesterone-mediated oocyte maturation 💬
 1件: MAP2K1 💬 D09666 💬 Selumetinib 1件: 34 💬
1262 Progesterone-mediated oocyte maturation 💬
 1件: MAP2K1 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1263 Prolactin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1264 Prolactin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1265 Prolactin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1266 Prolactin signaling pathway 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1267 Prolactin signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1268 Propanoate metabolism 💬
 1件: ABAT 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
1269 Prostate cancer 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
1270 Prostate cancer 💬
 3件: BRAF, PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1271 Prostate cancer 💬
 3件: BRAF, PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1272 Prostate cancer 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1273 Prostate cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
1274 Prostate cancer 💬
 2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
1275 Prostate cancer 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
1276 Prostate cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1277 Prostate cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1278 Prostate cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1279 Prostate cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1280 Prostate cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1281 Prostate cancer 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1282 Prostate cancer 💬
 1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1283 Prostate cancer 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1284 Prostate cancer 💬
 2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1285 Prostate cancer 💬
 2件: PDGFRA, PDGFRB 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
1286 Prostate cancer 💬
 2件: PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
1287 Proteoglycans in cancer 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
1288 Proteoglycans in cancer 💬
 3件: BRAF, KDR, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1289 Proteoglycans in cancer 💬
 3件: BRAF, KDR, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1290 Proteoglycans in cancer 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1291 Proteoglycans in cancer 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
1292 Proteoglycans in cancer 💬
 2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
1293 Proteoglycans in cancer 💬
 2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
1294 Proteoglycans in cancer 💬
 1件: KDR 💬 D03218 💬 Axitinib 1件: 34 💬
1295 Proteoglycans in cancer 💬
 1件: KDR 💬 D08881 💬 Cediranib 1件: 34 💬
1296 Proteoglycans in cancer 💬
 1件: KDR 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
1297 Proteoglycans in cancer 💬
 1件: KDR 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
1298 Proteoglycans in cancer 💬
 2件: KDR, MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
1299 Proteoglycans in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1300 Proteoglycans in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1301 Proteoglycans in cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1302 Proteoglycans in cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1303 Proteoglycans in cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1304 Proteoglycans in cancer 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1305 Proteoglycans in cancer 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
1306 Proteoglycans in cancer 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1307 Proteoglycans in cancer 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1308 Proteoglycans in cancer 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1309 Proteoglycans in cancer 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1310 Rap1 signaling pathway 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
1311 Rap1 signaling pathway 💬
 6件: BRAF, FLT4, KDR, KIT, PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1312 Rap1 signaling pathway 💬
 6件: BRAF, FLT4, KDR, KIT, PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1313 Rap1 signaling pathway 💬
 7件: CSF1, FLT1, FLT4, KDR, KIT, PDGFRA, PDGFRB 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
1314 Rap1 signaling pathway 💬
 7件: CSF1, FLT1, FLT4, KDR, KIT, PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
1315 Rap1 signaling pathway 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1316 Rap1 signaling pathway 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
1317 Rap1 signaling pathway 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
1318 Rap1 signaling pathway 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
1319 Rap1 signaling pathway 💬
 3件: FLT1, FLT4, KDR 💬 D03218 💬 Axitinib 1件: 34 💬
1320 Rap1 signaling pathway 💬
 3件: FLT1, FLT4, KDR 💬 D08881 💬 Cediranib 1件: 34 💬
1321 Rap1 signaling pathway 💬
 2件: KDR, MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
1322 Rap1 signaling pathway 💬
 2件: KIT, PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1323 Rap1 signaling pathway 💬
 2件: KIT, PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1324 Rap1 signaling pathway 💬
 3件: KIT, PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1325 Rap1 signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1326 Rap1 signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1327 Rap1 signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1328 Rap1 signaling pathway 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1329 Rap1 signaling pathway 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1330 Ras signaling pathway 💬
 3件: ABL1, KIT, PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1331 Ras signaling pathway 💬
 3件: ABL1, KIT, PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1332 Ras signaling pathway 💬
 4件: ABL1, KIT, PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1333 Ras signaling pathway 💬
 8件: CSF1, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
1334 Ras signaling pathway 💬
 8件: CSF1, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
1335 Ras signaling pathway 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1336 Ras signaling pathway 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
1337 Ras signaling pathway 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
1338 Ras signaling pathway 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
1339 Ras signaling pathway 💬
 3件: FLT1, FLT4, KDR 💬 D03218 💬 Axitinib 1件: 34 💬
1340 Ras signaling pathway 💬
 3件: FLT1, FLT4, KDR 💬 D08881 💬 Cediranib 1件: 34 💬
1341 Ras signaling pathway 💬
 6件: FLT3, FLT4, KDR, KIT, PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1342 Ras signaling pathway 💬
 6件: FLT3, FLT4, KDR, KIT, PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1343 Ras signaling pathway 💬
 2件: KDR, MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
1344 Ras signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1345 Ras signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1346 Ras signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1347 Ras signaling pathway 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1348 Ras signaling pathway 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1349 Regulation of actin cytoskeleton 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
1350 Regulation of actin cytoskeleton 💬
 3件: BRAF, PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1351 Regulation of actin cytoskeleton 💬
 3件: BRAF, PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1352 Regulation of actin cytoskeleton 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1353 Regulation of actin cytoskeleton 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
1354 Regulation of actin cytoskeleton 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
1355 Regulation of actin cytoskeleton 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
1356 Regulation of actin cytoskeleton 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1357 Regulation of actin cytoskeleton 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1358 Regulation of actin cytoskeleton 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1359 Regulation of actin cytoskeleton 💬
 1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1360 Regulation of actin cytoskeleton 💬
 1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1361 Regulation of actin cytoskeleton 💬
 2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1362 Regulation of actin cytoskeleton 💬
 2件: PDGFRA, PDGFRB 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
1363 Regulation of actin cytoskeleton 💬
 2件: PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
1364 Regulation of lipolysis in adipocytes 💬
 2件: PTGS1, PTGS2 💬 D00217 💬 Acetaminophen 16件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
1365 Regulation of lipolysis in adipocytes 💬
 2件: PTGS1, PTGS2 💬 D00109 💬 Acetylsalicylic acid 14件: 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
1366 Regulation of lipolysis in adipocytes 💬
 2件: PTGS1, PTGS2 💬 D00903 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1367 Regulation of lipolysis in adipocytes 💬
 2件: PTGS1, PTGS2 💬 D00904 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1368 Regulation of lipolysis in adipocytes 💬
 2件: PTGS1, PTGS2 💬 D07816 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1369 Regulation of lipolysis in adipocytes 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 9件:  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
1370 Relaxin signaling pathway 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1371 Relaxin signaling pathway 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
1372 Relaxin signaling pathway 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
1373 Relaxin signaling pathway 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
1374 Relaxin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1375 Relaxin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1376 Relaxin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1377 Relaxin signaling pathway 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1378 Relaxin signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1379 Relaxin signaling pathway 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1380 Relaxin signaling pathway 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1381 Renal cell carcinoma 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
1382 Renal cell carcinoma 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1383 Renal cell carcinoma 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1384 Renal cell carcinoma 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1385 Renal cell carcinoma 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1386 Renal cell carcinoma 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1387 Renal cell carcinoma 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
1388 Renal cell carcinoma 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1389 Renal cell carcinoma 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1390 Retrograde endocannabinoid signaling 💬
 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D00549 💬 Propofol 9件:  6 , 21, 22, 34, 46, 75, 84, 98, 296 💬
1391 Retrograde endocannabinoid signaling 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 16件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
1392 Retrograde endocannabinoid signaling 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 14件: 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
1393 Retrograde endocannabinoid signaling 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 9件:  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
1394 Retrograde endocannabinoid signaling 💬
 1件: PTGS2 💬 D00903 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1395 Retrograde endocannabinoid signaling 💬
 1件: PTGS2 💬 D00904 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1396 Retrograde endocannabinoid signaling 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1397 Rheumatoid arthritis 💬
 5件: CCL2, IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1398 Rheumatoid arthritis 💬
 2件: CSF1, FLT1 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
1399 Rheumatoid arthritis 💬
 2件: CSF1, FLT1 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
1400 Rheumatoid arthritis 💬
 1件: FLT1 💬 D03218 💬 Axitinib 1件: 34 💬
1401 Rheumatoid arthritis 💬
 1件: FLT1 💬 D08881 💬 Cediranib 1件: 34 💬
1402 Rheumatoid arthritis 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1403 Rheumatoid arthritis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
1404 Rheumatoid arthritis 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1405 Rheumatoid arthritis 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1406 RIG-I-like receptor signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
1407 RIG-I-like receptor signaling pathway 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1408 RIG-I-like receptor signaling pathway 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1409 Salmonella infection 💬
 3件: IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1410 Salmonella infection 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1411 Salmonella infection 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1412 Salmonella infection 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1413 Salmonella infection 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1414 Salmonella infection 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1415 Salmonella infection 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1416 Salmonella infection 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
1417 Salmonella infection 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D01068 💬 Vinblastine 1件: 34 💬
1418 Salmonella infection 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08675 💬 Vinblastine 1件: 34 💬
1419 Salmonella infection 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D02197 💬 Vincristine 3件: 26, 34, 331 💬
1420 Salmonella infection 💬
 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08679 💬 Vincristine 3件: 26, 34, 331 💬
1421 Serotonergic synapse 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
1422 Serotonergic synapse 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1423 Serotonergic synapse 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1424 Serotonergic synapse 💬
 3件: GABRB1, GABRB2, GABRB3 💬 D00549 💬 Propofol 9件:  6 , 21, 22, 34, 46, 75, 84, 98, 296 💬
1425 Serotonergic synapse 💬
 1件: MAP2K1 💬 D10604 💬 Binimetinib 1件: 34 💬
1426 Serotonergic synapse 💬
 1件: MAP2K1 💬 D09666 💬 Selumetinib 1件: 34 💬
1427 Serotonergic synapse 💬
 1件: MAP2K1 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1428 Serotonergic synapse 💬
 2件: PTGS1, PTGS2 💬 D00217 💬 Acetaminophen 16件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
1429 Serotonergic synapse 💬
 2件: PTGS1, PTGS2 💬 D00109 💬 Acetylsalicylic acid 14件: 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
1430 Serotonergic synapse 💬
 2件: PTGS1, PTGS2 💬 D00903 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1431 Serotonergic synapse 💬
 2件: PTGS1, PTGS2 💬 D00904 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1432 Serotonergic synapse 💬
 2件: PTGS1, PTGS2 💬 D07816 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1433 Serotonergic synapse 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 9件:  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
1434 Shigellosis 💬
 1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1435 Shigellosis 💬
 1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
1436 Shigellosis 💬
 1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
1437 Shigellosis 💬
 1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
1438 Shigellosis 💬
 2件: IL1B, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1439 Shigellosis 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1440 Shigellosis 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1441 Shigellosis 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1442 Shigellosis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
1443 Shigellosis 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1444 Signaling pathways regulating pluripotency of stem cells 💬
 1件: BMPR2 💬 D03779 💬 Dibotermin alfa 1件: 34 💬
1445 Signaling pathways regulating pluripotency of stem cells 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1446 Signaling pathways regulating pluripotency of stem cells 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1447 Signaling pathways regulating pluripotency of stem cells 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1448 Signaling pathways regulating pluripotency of stem cells 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1449 Signaling pathways regulating pluripotency of stem cells 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1450 Small cell lung cancer 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 16件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
1451 Small cell lung cancer 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 14件: 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
1452 Small cell lung cancer 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 9件:  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
1453 Small cell lung cancer 💬
 1件: PTGS2 💬 D00903 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1454 Small cell lung cancer 💬
 1件: PTGS2 💬 D00904 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1455 Small cell lung cancer 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1456 Sphingolipid signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1457 Sphingolipid signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1458 Sphingolipid signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1459 Sphingolipid signaling pathway 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1460 Sphingolipid signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1461 Sphingolipid signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
1462 Sphingolipid signaling pathway 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1463 Sphingolipid signaling pathway 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1464 Spinocerebellar ataxia 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1465 Spinocerebellar ataxia 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1466 Spinocerebellar ataxia 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1467 Staphylococcus aureus infection 💬
 1件: IL10 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1468 Synaptic vesicle cycle 💬
 2件: SLC6A2, SLC6A3 💬 D01296 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
1469 Synaptic vesicle cycle 💬
 2件: SLC6A2, SLC6A3 💬 D04999 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
1470 Systemic lupus erythematosus 💬
 2件: IL10, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1471 Systemic lupus erythematosus 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
1472 Systemic lupus erythematosus 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1473 T cell receptor signaling pathway 💬
 2件: IL10, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1474 T cell receptor signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1475 T cell receptor signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1476 T cell receptor signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1477 T cell receptor signaling pathway 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1478 T cell receptor signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1479 T cell receptor signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
1480 T cell receptor signaling pathway 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1481 Taste transduction 💬
 6件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6 💬 D00549 💬 Propofol 9件:  6 , 21, 22, 34, 46, 75, 84, 98, 296 💬
1482 Taste transduction 💬
 3件: SCN2A, SCN3A, SCN9A 💬 D00354 💬 Lamotrigine 5件: 13, 34, 38, 114, 144 💬
1483 Taste transduction 💬
 3件: SCN2A, SCN3A, SCN9A 💬 D00358 💬 Lidocaine 12件:  6 , 13, 34, 46, 51, 70, 84, 86, 168, 226, 231, 256 💬
1484 Taste transduction 💬
 3件: SCN2A, SCN3A, SCN9A 💬 D02086 💬 Lidocaine 12件:  6 , 13, 34, 46, 51, 70, 84, 86, 168, 226, 231, 256 💬
1485 Taste transduction 💬
 3件: SCN2A, SCN3A, SCN9A 💬 D08127 💬 Lidocaine 12件:  6 , 13, 34, 46, 51, 70, 84, 86, 168, 226, 231, 256 💬
1486 Taurine and hypotaurine metabolism 💬
 2件: GAD1, GAD2 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
1487 Terpenoid backbone biosynthesis 💬
 2件: FNTA, FNTB 💬 D03720 💬 Tipifarnib 1件: 34 💬
1488 Terpenoid backbone biosynthesis 💬
 1件: HMGCR 💬 D00359 💬 Lovastatin 11件:  6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
1489 Terpenoid backbone biosynthesis 💬
 1件: HMGCR 💬 D00434 💬 Simvastatin 21件:  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
1490 TGF-beta signaling pathway 💬
 1件: BMPR2 💬 D03779 💬 Dibotermin alfa 1件: 34 💬
1491 TGF-beta signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
1492 TGF-beta signaling pathway 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1493 TGF-beta signaling pathway 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1494 Th17 cell differentiation 💬
 2件: IL1B, IL6 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1495 Th17 cell differentiation 💬
 1件: IL6 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1496 Th17 cell differentiation 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1497 Th17 cell differentiation 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1498 Th17 cell differentiation 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1499 Thermogenesis 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1500 Thermogenesis 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1501 Thermogenesis 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1502 Thyroid cancer 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
1503 Thyroid cancer 💬
 2件: BRAF, RET 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1504 Thyroid cancer 💬
 2件: BRAF, RET 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1505 Thyroid cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1506 Thyroid cancer 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1507 Thyroid cancer 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1508 Thyroid cancer 💬
 1件: RET 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
1509 Thyroid cancer 💬
 1件: RET 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
1510 Thyroid hormone signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1511 Thyroid hormone signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1512 Thyroid hormone signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1513 Thyroid hormone signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1514 Thyroid hormone signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1515 Thyroid hormone signaling pathway 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1516 Thyroid hormone signaling pathway 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1517 Thyroid hormone signaling pathway 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1518 Tight junction 💬
 1件: ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
1519 Tight junction 💬
 1件: ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
1520 TNF signaling pathway 💬
 4件: CCL2, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1521 TNF signaling pathway 💬
 1件: CSF1 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
1522 TNF signaling pathway 💬
 1件: CSF1 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
1523 TNF signaling pathway 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1524 TNF signaling pathway 💬
 1件: MAP2K1 💬 D10604 💬 Binimetinib 1件: 34 💬
1525 TNF signaling pathway 💬
 1件: MAP2K1 💬 D09666 💬 Selumetinib 1件: 34 💬
1526 TNF signaling pathway 💬
 1件: MAP2K1 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1527 TNF signaling pathway 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 16件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
1528 TNF signaling pathway 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 14件: 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
1529 TNF signaling pathway 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 9件:  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
1530 TNF signaling pathway 💬
 1件: PTGS2 💬 D00903 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1531 TNF signaling pathway 💬
 1件: PTGS2 💬 D00904 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1532 TNF signaling pathway 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1533 TNF signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
1534 Toll-like receptor signaling pathway 💬
 2件: IFNAR1, IFNAR2 💬 D02745 💬 Interferon alfa-2b 2件: 25, 34 💬
1535 Toll-like receptor signaling pathway 💬
 3件: IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1536 Toll-like receptor signaling pathway 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1537 Toll-like receptor signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1538 Toll-like receptor signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1539 Toll-like receptor signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1540 Toll-like receptor signaling pathway 💬
 1件: TLR7 💬 D02500 💬 Imiquimod 2件: 34, 51 💬
1541 Toll-like receptor signaling pathway 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
1542 Toxoplasmosis 💬
 2件: IL10, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1543 Toxoplasmosis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
1544 Toxoplasmosis 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1545 Transcriptional misregulation in cancer 💬
 1件: FLT1 💬 D03218 💬 Axitinib 1件: 34 💬
1546 Transcriptional misregulation in cancer 💬
 1件: FLT1 💬 D08881 💬 Cediranib 1件: 34 💬
1547 Transcriptional misregulation in cancer 💬
 2件: FLT1, FLT3 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
1548 Transcriptional misregulation in cancer 💬
 2件: FLT1, FLT3 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
1549 Transcriptional misregulation in cancer 💬
 1件: FLT3 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1550 Transcriptional misregulation in cancer 💬
 1件: FLT3 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1551 Transcriptional misregulation in cancer 💬
 1件: IL6 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1552 Transcriptional misregulation in cancer 💬
 1件: IL6 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1553 Transcriptional misregulation in cancer 💬
 1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
1554 Tuberculosis 💬
 5件: IL10, IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1555 Tuberculosis 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1556 Tuberculosis 💬
 1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1557 Tuberculosis 💬
 1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1558 Tuberculosis 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
1559 Tuberculosis 💬
 1件: VDR 💬 D00188 💬 Cholecalciferol 23件:  6 , 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 84, 85, 96, 97, 162, 202, 228, 271, 298, 299 💬
1560 Type I diabetes mellitus 💬
 2件: GAD1, GAD2 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
1561 Type I diabetes mellitus 💬
 3件: IL1A, IL1B, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1562 Type I diabetes mellitus 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
1563 Type I diabetes mellitus 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1564 Type II diabetes mellitus 💬
 1件: CACNA1G 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
1565 Type II diabetes mellitus 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1566 Type II diabetes mellitus 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 40件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1567 Type II diabetes mellitus 💬
 1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1568 Type II diabetes mellitus 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
1569 Type II diabetes mellitus 💬
 1件: TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1570 Type II diabetes mellitus 💬
 1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1571 Valine, leucine and isoleucine degradation 💬
 1件: ABAT 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
1572 Vascular smooth muscle contraction 💬
 1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
1573 Vascular smooth muscle contraction 💬
 2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1574 Vascular smooth muscle contraction 💬
 2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1575 Vascular smooth muscle contraction 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1576 Vascular smooth muscle contraction 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1577 Vascular smooth muscle contraction 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1578 VEGF signaling pathway 💬
 1件: KDR 💬 D03218 💬 Axitinib 1件: 34 💬
1579 VEGF signaling pathway 💬
 1件: KDR 💬 D10062 💬 Cabozantinib 1件: 34 💬
1580 VEGF signaling pathway 💬
 1件: KDR 💬 D08881 💬 Cediranib 1件: 34 💬
1581 VEGF signaling pathway 💬
 1件: KDR 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
1582 VEGF signaling pathway 💬
 1件: KDR 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
1583 VEGF signaling pathway 💬
 2件: KDR, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
1584 VEGF signaling pathway 💬
 2件: KDR, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
1585 VEGF signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1586 VEGF signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1587 VEGF signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1588 VEGF signaling pathway 💬
 1件: PTGS2 💬 D00217 💬 Acetaminophen 16件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
1589 VEGF signaling pathway 💬
 1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 14件: 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
1590 VEGF signaling pathway 💬
 1件: PTGS2 💬 D00567 💬 Celecoxib 9件:  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
1591 VEGF signaling pathway 💬
 1件: PTGS2 💬 D00903 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1592 VEGF signaling pathway 💬
 1件: PTGS2 💬 D00904 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1593 VEGF signaling pathway 💬
 1件: PTGS2 💬 D07816 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1594 VEGF signaling pathway 💬
 1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1595 VEGF signaling pathway 💬
 1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1596 Viral myocarditis 💬
 1件: ABL1 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1597 Viral myocarditis 💬
 1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1598 Viral myocarditis 💬
 1件: ABL1 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1599 Viral protein interaction with cytokine and cytokine receptor 💬
 4件: CCL2, IL10, IL6, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1600 Viral protein interaction with cytokine and cytokine receptor 💬
 1件: CSF1 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
1601 Viral protein interaction with cytokine and cytokine receptor 💬
 1件: CSF1 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
1602 Viral protein interaction with cytokine and cytokine receptor 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1603 Viral protein interaction with cytokine and cytokine receptor 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬
1604 Yersinia infection 💬
 5件: CCL2, IL10, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1605 Yersinia infection 💬
 2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1606 Yersinia infection 💬
 2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
1607 Yersinia infection 💬
 2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
1608 Yersinia infection 💬
 2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
1609 Yersinia infection 💬
 1件: TNF 💬 D04687 💬 Lenalidomide 7件: 16, 26, 28, 34, 49, 284, 300 💬

先頭へ